¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"delayed hemolytic transfusion reaction"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 4 ÆäÀÌÁö: 2
¿µ¹® immunological reaction ÇÑ±Û ¸é¿ª¹ÝÀÀ
¼³¸í   
  »ýüÀÇ ¸ö ¾È¿¡¼­ »ý±ä ¹°ÁúÀ̳ª ¸ö ¹Û¿¡¼­ µé¾î¿Â ¹°ÁúÀÌ »ýü¿Í ´Ù¸¦ ¶§ ÀÚ±â Ã¼³»ÀÇ ÅëÀϼº°ú °³Ã¼ÀÇ »ýÁ¸ À¯Áö ¹× Á¾ÀÇ Á¸¼ÓÀ» À§ÇÏ¿© ±× ¹°ÁúµéÀ» Á¦°ÅÇϴ ÀÏ·ÃÀÇ »ýü ¹ÝÀÀ. ´Ù½Ã ¸»ÇØ B¼¼Æ÷¿¡ ÀÇÇÑ Ç×ü»ý»ê, T¼¼Æ÷¸¦ Áß½ÉÀ¸·Î Çϴ ¼¼Æ÷¼º ¸é¿ª, ¸é¿ª°ü¿ë, ¸é¿ª±â¾ï µîÀÇ »ýü ³» ¹ÝÀÀÀ» ¸»ÇÑ´Ù. Å«Æ÷½Ä¼¼Æ÷´Â Ç׿øÀ» Ã³¸®Çؼ­ Æ¯ÀÌÀûÀΠÇ׿ø°áÁ¤±â¸¦ °®´Â ºÐÀڷΠ¹Ù²ã, Ç׿ø°ú ÁÖ¿äÁ¶Á÷ ÀûÇÕÀ¯ÀüÀÚº¹ÇÕü¸¦ ¼¼Æ÷Ç¥¸é¿¡ Ç¥ÇöÇϸç, T¼¼Æ÷·Î Àü´ÞÇÑ´Ù. ÇÑÆí B¼¼Æ÷´Â Å«Æ÷½Ä¼¼Æ÷ ³»¿¡¼­ Ã³¸®µÈ Ç׿øÀÇ °áÁ¤±â¸¦ ÀνÄÇÏ¿© ´ëÀÀÇϴ ƯÀÌÀûÇ×ü¸¦ »ý»êÇÏ¿© Ç׿øÀ» Ã³¸®ÇÑ´Ù. 
¿µ¹® reaction formation ÇÑ±Û ¹Ýµ¿Çü¼º, ¹ÝÀÀÇü¼º
¼³¸í   
  ¾ï¾Ðº¸´Ù ´õ Àû±ØÀûÀΠ¹æ¾î¸ÞÄ¿´ÏÁòÀ̸ç, ¹«ÀǽÄÀûÀΠ»ý°¢, ¼Ò¿ø, Ã浿ÀÌ ³Ê¹«³ªµµ ¹Þ¾Æµé¿©Áú ¼ö ¾ø´Â °ÍÀÏ °æ¿ì¿¡ À̿ʹ Á¤¹Ý´ë ¹æÇâÀÇ °ÍÀ» °­Á¶ÇÔÀ¸·Î½á ±×·± ¹«ÀǽÄÀûÀΠ°ÍµéÀÌ ÀǽĵÇÁö ¾Ê°Ô Çϴ °úÁ¤. ¿¹¸¦ µé¸é °¡Àå °¡ÇÐÀûÀΠ¼º°ÝÀÇ »ç¶÷ÀÌ »ýÃ¼ÇØºÎ ¹Ý´ë·ÐÀÚ°¡ µÇ´Â °æ¿ì¸¦ µé ¼ö ÀÖ´Ù. À̰ÍÀº ¶Ç °¡½¿ ±íÀÌ Àá°ÜÀִ µÎ·Á¿òÀÌ ÀǽĵǴ °ÍÀ» ÇÇÇϱâ À§Çؼ­ µÎ·Á¿òÀÇ ´ë»óÀÌ µÇ´Â Çൿ¿¡ °ñ¸ôÇϴ °æ¿ìµµ Æ÷ÇÔÀÌ µÈ´Ù. ¿¹¸¦ µé¸é, ³²ÀÚ¿¡°Ô »óó¹ÞÁö ¾ÊÀ»±î Çϴ µÎ·Á¿ò¿¡ °¡µæ Âù ¼Ò³à°¡ ÀÌ °°Àº µÎ·Á¿òÀ» ºÎÁ¤ÇÏ·Á´Â ¼ö´ÜÀ¸·Î ³­ÀâÇÑ ¼ºÇàÀ§¿¡ °ñ¸ôÇϴ °æ¿ì°¡ ÀÖ´Ù. ¶Ç ÀüóÀÇ Àڳฦ ¹Ì¿öÇϴ °è¸ð°¡ ¿ÀÈ÷·Á Áö³ªÄ¥ Á¤µµ·Î ±× ¾ÆÀ̸¦ ±Í¿©¿öÇϴ ÀÏ µûÀ§ÀÌ´Ù. 
¿µ¹® complement fixation reaction ÇÑ±Û º¸Ã¼°áÇÕ ¹ÝÀÀ, µµ¿òü°áÇÕ¹ÝÀÀ
¼³¸í   
  Ç×ü¿ÍÀÇ ¹ÝÀÀ¿¡ À־ º¸Ã¼¿Í °áÇÕÇϴ Ç×ü¸¦ °Ë»çÇϴ ¹æ¹ýÀ¸·Î, ÀÌ ¹ÝÀÀÀº ÃÖÃÊ¿¡ ±âÁöÇ׿ø, ÇǰËÇ÷û ¹× º¸Ã¼¸¦ È¥ÇÕÇÑ´Ù. Á¦2´Ü°è¿¡¼­´Â ÀûÇ÷±¸¿Í À̰Ϳ¡ ´ëÀÀÇϴ ¿ëÇ÷¼ÒÀǠȥÇÕ¾×À» °¡ÇÑ´Ù. º» ¹ÝÀÀÈÄ ¿ëÇ÷ÀÌ ÀϾÁö ¾ÊÀ¸¸é º»Ã¼´Â Ç׿øÇ×ü°áÇÕ¹°¿¡ °áÇÕÇÑ °ÍÀÌ µÇ¾î ¾ç¼ºÀÌ µÇÁö¸¸, ¿ëÇ÷ÀÌ ÀϾ °æ¿ì º¸Ã¼´Â °áÇÕÇÏÁö ¾Ê¾Æ ¼ÒºñµÇÁö ¾Ê±â ¶§¹®¿¡ À½¼ºÀÌ µÈ´Ù. º» ¹ÝÀÀÀº ±âÁöÇ÷ûÀ» ½á¼­ Ç׿ø°ËÃâ¿¡ ÀÀ¿ëÇÒ ¼ö ÀÖÀ¸¸ç, ¸¶ÀÌÄÚÇö󽺸¶, ¸®ÄÉí, Å¬¶ó¹Ìµð¾Æ, ¹ÙÀÌ·¯½º, ¸Åµ¶ µîÀÇ Áø´Ü¿¡ ¾²ÀδÙ.
  
  
¿µ¹® graft versus host reaction ÇÑ±Û ÀÌ½ÄÆí´ë ¼÷ÁÖ¹ÝÀÀ
¼³¸í   
  ¸é¿ªÀ̶õ ÀÚ½ÅÀÇ °Í°ú ÀÚ½ÅÀÇ °ÍÀÌ ¾Æ´Ñ °ÍÀ» ±¸ºÐÇØ¼­ ÀÚ½ÅÀÇ °ÍÀÌ ¾Æ´Ñ °ÍÀ» °ø°ÝÇÏ¿© »ý¹°ÇÐÀû È°¼ºÀ» ¾ø¾Ö°Å³ª Á¦°ÅÇϴ °ÍÀÌ´Ù. ÀÌ ¸é¿ªÀº ÁַΠÇ÷¾×¿¡ Àִ ¼¼Æ÷¿¡ ÀÇÇØ¼­ ÀÌ·ç¾îÁø´Ù. Æ¯È÷ ¸²ÇÁ±¸´Â ÀÌ ¸é¿ª¿¡ ÁßÃßÀûÀΠ¿ªÇÒÀ» Çϴ ¼¼Æ÷ÀÌ´Ù. ÀÌ½ÄÆí´ë¼÷ÁÖ¹ÝÀÀÀ̶ó´Â °ÍÀº À̽ĵǾî¿Â Á¶Á÷¿¡ Á¸ÀçÇϴ ŸÀÎÀÇ Ç÷±¸µéÀÌ ¼÷ÁÖÀÇ ¼¼Æ÷¸¦ °ø°ÝÇϴ °ÍÀ» ¸»ÇÑ´Ù. Áï À̽ĵǾî¿Â Á¶Á÷°ú ÇÔ²² µé¾î¿Â Ç÷±¸µéÀÌ À̽ÄÀ» ¹ÞÀº »ç¶÷ÀÇ ¼¼Æ÷¸¦ Å¸ÀÎÀÇ °ÍÀ¸·Î ÀÎÁöÇØ¼­ °ø°ÝÇϴ Çö»óÀÌ´Ù. À̰ÍÀº À̽ÄÀ» ¹ÞÀº »ç¶÷ÀÇ ¸é¿ª»óŰ¡ Á¤»óÀûÀÏ °æ¿ì¿¡´Â ÀϾÁö ¾Ê´Âµ¥ ¿Ö³ÄÇϸ頸鿪»óŰ¡ Á¤»óÀÏ °æ¿ì¿¡´Â À̽ĵǾî¿Â Àå±â¿Í ´õºÒ¾î µé¾î¿Â Å¸ÀÎÀÇ Ç÷±¸µéÀ» À̽ÄÀ» ¹ÞÀº »ç¶÷ÀÇ Ç÷±¸°¡ Å¸ÀÎÀÇ °ÍÀ¸·Î ÀÎÁöÇØ¼­ °ø°ÝÀ» ÇÏ°í ¼ýÀûÀ¸·Î À¯¸®ÇÏ¿© ¸ðµÎ Á×ÀÏ ¼ö°¡ Àֱ⠶§¹®ÀÌ´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • fetomaternal transfusion
    žƸðü¼öÇ÷
  • fetus to fetus transfusion
    žƻçÀ̼öÇ÷
  • immediate transfusion
    Áï½Ã¼öÇ÷, ¹Ù·Î¼öÇ÷
  • incompatible blood transfusion
    ºÎÀûÇÕ¼öÇ÷
  • intramedullary transfusion
    °ñ¼ö¼Ó¼öÇ÷, °ñ¼ö³»¼öÇ÷
  • massive transfusion
    ´ë·®¼öÇ÷
  • placental transfusion syndrome
    ŹݼöÇ÷ÁõÈıº
  • plasma component transfusion
    Ç÷À强ºÐ¼öÇ÷
  • post-transfusion hepatitis
    ¼öÇ÷Èİ£¿°
  • post-transfusion thrombocytopenia
    ¼öÇ÷ÈÄÇ÷¼ÒÆÇ°¨¼Ò(Áõ)
  • substitution transfusion
    ´ëÄ¡¼öÇ÷, ±³È¯¼öÇ÷
  • autoimmune hemolytic anemia
    ÀÚ°¡¸é¿ª¿ëÇ÷ºóÇ÷
  • alloimmune hemolytic anemia
    µ¿Á¾¸é¿ª¿ëÇ÷ºóÇ÷
  • congenital hemolytic anemia
    ¼±Ãµ¿ëÇ÷ºóÇ÷
  • drug-induced hemolytic anemia
    ¾à¹°À¯¹ß¿ëÇ÷ºóÇ÷
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • reaction fever
    ¹ÝÀÀ¿­
  • reaction
    ¹ÝÀÀ
  • adjustment reaction
    ÀûÀÀ¹ÝÀÀ
  • adverse drug reaction
    ¾à¹°ºÎÀÛ¿ë
  • agglutination reaction
    ÀÀÁý¹ÝÀÀ
  • allergic reaction
    ¾Ë·¹¸£±â¹ÝÀÀ
  • antigen-antibody reaction
    Ç׿øÇ×ü¹ÝÀÀ
  • anxiety reaction
    ºÒ¾È¹ÝÀÀ
  • cascade reaction
    ¿¬¼âÁõÆø¹ÝÀÀ
  • chain reaction
    ¿¬¼â¹ÝÀÀ
  • complement fixation reaction
    µµ¿òü°áÇÕ¹ÝÀÀ, º¸Ã¼°áÇÕ¹ÝÀÀ
  • cross reaction
    ±³Â÷¹ÝÀÀ
  • graft versus host reaction
    ÀÌ½ÄÆí´ë¼÷ÁÖ¹ÝÀÀ
  • inhibition reaction
    ¾ïÁ¦¹ÝÀÀ
  • initial reaction
    Ãʱâ¹ÝÀÀ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • direct transfusion
    (¢¡immediate transfusion) Áï½Ã¼öÇ÷, ¹Ù·Î¼öÇ÷
  • exchange transfusion
    ±³È¯¼öÇ÷
  • exsanguination transfusion
    (¢¡exchange transfusion) ±³È¯¼öÇ÷
  • post-transfusion hepatitis
    ¼öÇ÷Èİ£¿°
  • transfusion hepatitis
    (¢¡post-transfusion hepatitis) ¼öÇ÷Èİ£¿°
  • immediate transfusion
    Áï½Ã¼öÇ÷, ¹Ù·Î¼öÇ÷
  • incompatible blood transfusion
    ºÎÀûÇÕ¼öÇ÷
  • indirect transfusion
    °£Á¢¼öÇ÷
  • transfusion-transmitted infection
    ¼öÇ÷ÀüÆÄ°¨¿°
  • massive transfusion
    ´ë·®¼öÇ÷
  • plasma component transfusion
    Ç÷À强ºÐ¼öÇ÷
  • post-transfusion thrombocytopenia
    ¼öÇ÷ÈÄÀúÇ÷¼ÒÆÇÁõ
  • substitution transfusion
    (¢¡exchange transfusion) ±³È¯¼öÇ÷
  • transfusion
    ¼öÇ÷
  • alloimmune hemolytic anemia
    µ¿Á¾¸é¿ª¿ëÇ÷ºóÇ÷
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • post transfusion purpura
    ¼öÇ÷ÈÄÀÚ¹ÝÁõ(âÃúìý­í¹Úèñø)
  • post-transfusion thrombocytopenia
    ¼öÇ÷ÈÄÇ÷¼ÒÆÇ°¨¼ÒÁõ
  • pre-transfusion testing
    ¼öÇ÷Àü°Ë»ç
  • ABO hemolytic disease
    ABO ¿ëÇ÷¼º Áúȯ(¡­éÁúìàõ òðü´)
  • ABO hemolytic disease of the newborn
    ½Å»ý¾Æ ABO ¿ëÇ÷¼ºÁúȯ
  • Hemolytic icterus, congenital
    ¿ëÇ÷¼ºÈ²´Þ(éÁúìàõüÜÓ¸)
  • acute hemolytic anemia
    ±Þ¼º ¿ëÇ÷¼º ºóÇ÷(¡­éÁúìàõÞ¸úì).
  • acute hemolytic anemia
    ±Þ¼º ¿ëÇ÷¼º ºóÇ÷(?ËíÌ´ËÛË×Ì´).
  • anemia hemolytic
    ¿ëÇ÷¼º ºóÇ÷.
  • anemia,hemolytic
    ¿ëÇ÷¼º(éÁúìàõ)
  • antibody, hemolytic
    ¿ëÇ÷¼ºÇ×ü
  • heat induced hemolytic anemia
    ¿­À¯¹ß¼º ¿ëÇ÷¼º ºóÇ÷
  • hemolytic
    ¿ëÇ÷Á¦, ¿ëÇ÷¼º(éÁúìàõ)ÀÇ.
  • hemolytic
    ¿ëÇ÷Á¦, ¿ëÇ÷¼º(ËíÌ´ËÛ)ÀÇ.
  • hemolytic activity
    ¿ëÇ÷´É
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • pas reaction ; periodic acld schiff reaction
    PAS ¹ÝÀÀ<¿°»ö>(¡­Úãëë<æøßä>)
  • untoward effect =adverse reaction, unwanted reaction
    À¯ÇعÝÀÀ(êóúªÚãëë), ºÎÀÛ¿ë
  • untoward effect =adverse reaction, unwanted reaction
    À¯ÇعÝÀÀ(êóúªÚãëë), ¾àÇØ(å·úª)¹ÝÀÀ.[¾à¸®]ºÎÀÛ¿ë, ºÒ¿øÀÛ¿ë.
  • upgrading reaction => reversal reaction
    ¿ªÇà¹ÝÀÀ
  • delayed
    Áö¿¬(¼º)ÀÇ, ÈĹß(¼º)ÀÇ, ¼Ó¹ß(¼º)ÀÇ.
  • delayed sense
    °¨°¢ÀÇ Á¡°¨.
  • delayed action
    Áö¿¬ÀÛ¿ë(¡­íÂéÄ).
  • delayed allergy = retarded a
    Áö¿¬¼º ¾Ë·¹¸£±â
  • delayed allergy =retarded a.
    Áö¿¬¼º ¾Ë·¹¸£±â.
  • delayed apoplexy
    Áö¿¬Á¹Áß.
  • delayed conditioned reflex
    Áö¿¬Á¶°Ç¹Ý»ç(¡­ðÉËìÚãÞÒ).
  • delayed conduction
    Áö¿¬Àüµµ(òÀæÅîîÔ³).
  • delayed delivery
    Áö¿¬ºÐ¸¸(òÀæÅÝÂØ´).
  • delayed dentition
    »ýÄ¡Áö¿¬(ßæöÍòÀæÅ).
  • delayed dermographism
    Áö¿¬¼º ÇǺ馱âÁõ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • anaplerotic reaction
    º¸Àü¹ÝÀÀ(ÜÍîóÚãëë)
  • annulation reaction
    ȯ»óÇü¼º ¹ÝÀÀ(ü»ßÒû¡à÷Úãëë)
  • anthrone reaction
    ¾ÈÆ®·Ð ¹ÝÀÀ(Úãëë)
  • antigen-antibody reaction
    Ç׿øÇ×ü ¹ÝÀÀ(ù÷ê«ù÷ô÷Úãëë)
  • Arthus reaction
    ¾Æ¸£Åõ½º ¹ÝÀÀ(Úãëë)
  • Berthelot reaction
    º£¸£ÅÐ·Ô ¹ÝÀÀ(Úãëë)
  • Bial's reaction
    ºñ¾Ë ¹ÝÀÀ(Úãëë)
  • bimolecular reaction
    À̺ÐÀÚ ¹ÝÀÀ(ì£ÝÂí­Úãëë)
  • bireactant reaction
    µÎ ¹ÝÀÀ¹°(ÚãëëÚª) ¹ÝÀÀ(Úãëë)
  • bisubstrate reaction
    µÎ ±âÁú(Ðñòõ) ¹ÝÀÀ(Úãëë)
  • biuret reaction
    ºß·¿ ¹ÝÀÀ(Úãëë)
  • capsule swelling reaction
    ĸ½¶ ÆØÃ¢¹ÝÀÀ(ø³óìÚãëë)
  • Carr-Price reaction
    Ä«¸£-ÇÁ¶óÀ̽º ¹ÝÀÀ(Úãëë)
  • chain reaction
    ¿¬¼â¹ÝÀÀ(ææáðÚãëë)
  • chemical reaction
    È­ÇйÝÀÀ(ûùùÊÚãëë)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 4 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • periosteal reaction
    °ñ¸·¹ÝÀÀ
  • pyrogenic reaction
    ¹ß¿­¹ÝÀÀ
  • reaction
    ¹ÝÀÀ
  • side reaction
    ºÎÀÛ¿ë, ºÎ¹ÝÀÀ
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
LR labeled release; laboratory references; laboratory report; labor room; lactated Ringer [solution]; l...
MAHA Micro-Angiopathic Hemolytic Anemia; PB»ó Helmet Cell
  ThrombocytopeniaÁß MAHAÀ¯¹ß
&nbs...
DHR delayed hypersensitivity reaction; Department of Human Resources
DSHR delayed skin hypersensitivity reaction
TR recovery time; rectal temperature; repetition time; residual tuberculin; terminal repeat; tetrazoliu...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
CH 50 Complement hemolytic activity
GABHS Group A beta hemolytic streptococcal
GBS Group B beta hemolytic streptococci
GBS Group B beta--hemolytic streptococcus
MAHA Microangiopathic hemolytic anemia
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • delayed reflex
    Áö¿¬ ¹Ý»ç
    ¿øÀÎÀÌ µÇ´Â ÀÚ±ØÀÌ °¡ÇØÁø ÈÄ Àá½Ã ÀÖ´Ù°¡ ÀϾ´Â ¹Ý»ç.
  • delayed sensation
    Áö¿¬ °¨°¢
    ÀÏÁ¤ ½Ã°£ °æ°ú ÈÄ °¨°¢À» ´À³¢´Â °Í.
  • delayed side tone test
    ¿Ï¼Ó¾îÀ½ ûÃë °Ë»ç¹ý
  • delayed symptom
    Áö¿¬ Áõ»ó
    ±× Áúº´À» ÀÏÀ¸Å°´Â ¿øÀÎÀÌ ÀÖÀº ÈÄ¿¡ ÀÏÁ¤ ±â°£µ¿¾ÈÀº ³ªÅ¸³ªÁö ¾Ê¾Ò´Ù°¡ ÃßÈÄ¿¡ ³ªÅ¸³ª´Â °Í.
  • delayed-onset muscle soreness
    Áö¿¬¼º ±ÙÅëÁõ
    °£ÇæÀûÀÎ °ú»ç¿ë
  • delayed-type hyperseneitivity
    Áö¿¬Çü °ú¹ÎÁõ
    °¨ÀÛµÈ T ¸²ÇÁ±¸¿¡ ÀÇÇÏ¿© Àü´ÞµÇ´Â °ú¹ÎÁõ. Ç×ü¿¡ ÀÇÇÏ¿© ¹ß»ýÇÏ´Â °ú¹ÎÁõÀÌ ¾Æ´Ï°í º¸Åë ¸²ÇÁ±¸¿Í macro
  • exchange transfusion
    ±³È¯ ¼öÇ÷
    ȯÀÚÀÇ ÀüÇ÷¾×À» °øÇ÷ÀÚÀÇ Ç÷¾×À¸·Î ġȯÇÏ´Â ¹æ¹ýÀÌ¸ç ½Å»ý¾ÆÀÇ ¿ëÇ÷¼º ºóÇ÷ µî¿¡ »ç¿ëµÈ´Ù.
  • immediate transfusion
    Á÷Á¢ ¼öÇ÷, Áï°¢ ¼öÇ÷, Áï½Ã ¼öÇ÷
    Áß°£ ¿ë±â³ª Ç×ÀÀ°íÁ¦¸¦ »ç¿ëÇÏÁö ¾Ê°í, ¾î¶² »ç¶÷À¸·ÎºÎÅÍ ´Ù¸¥ »ç¶÷¿¡°Ô·Î Ç÷¾×À» Á÷Á¢ ¿Å±â´Â °Í.
  • incompatible blood transfusion
    ºÎÀûÇÕ ¼öÇ÷
  • malaria transfusion
    ¼öÇ÷ ¸»¶ó¸®¾Æ
    ¿À¿°µÈ ÁÖ»ç ¹Ù´ÃÀÇ ¿ì¹ßÀû °¨¿°À̳ª, ÁÖ»ç ¹Ù´ÃÀ» °øµ¿À¸·Î »ç¿ëÇÏ´Â ¾à¹° Ž´ÐÀÚ¿¡ ÀÇÇØ¼­ °øÇ÷ÀڷκÎÅÍ Á÷Á¢ ÀüÆÄµÇ´Â Plasmodium malariae, Plasmodium vivax, Plasmodium ovaleÀÇ °¨¿°.
  • platelet transfusion
    Ç÷¼ÒÆÇ ¼öÇ÷
  • post-transfusion thrombocytopenia
    ¼öÇ÷ÈÄ Ç÷¼ÒÆÇ °¨¼ÒÁõ
  • serum transfusion
    Ç÷û ¼öÇ÷
  • transfusion
    ¼öÇ÷, ¼ö¾×
    ÀüÇ÷À̳ª Ç÷¾× ¼ººÐÀÌ Ç÷·ù·Î Á÷Á¢ µé¾î°¡´Â °Í.
  • transfusion procedure
    ¼öÇ÷ óġ
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
delayed flap A flap raised in its donor area in two or more stages to increase its chances of survival after transfer.
(05 Mar 2000)
delayed gastric emptying <gastroenterology> A condition where there is delayed stomach emptying (due abnormal gastric motility), often see as a complication of diabetes mellitus.
Risk factors include diabetes, systemic sclerosis, previous vagotomy, previous gastrectomy, viceral neuropathy and the use of anticholinergic medications.
Symptoms include bloating, nausea, vomiting and constipation. Treatment include dietary modification and the use of cholinergic medications and metachlopromide.
(27 Sep 1997)
delayed graft Application of a skin graft after waiting several days for healthy granulations to form.
(05 Mar 2000)
delayed hypersensitivity <immunology> Hypersensitivity (increased reaction by the body to a foreign substance such as an antigen or allergen) that does not appear until 24 to 48 hours after the body is exposed to the foreign substance.
(09 Oct 1997)
delayed implantation A phenomenon characterised by an interval ranging from a few weeks to approximately 6 months between the time an ovum is fertilised and subsequent implantation of the zygote, as in the marten and the armadillo.
(05 Mar 2000)
delayed rectifier channel <physiology> The potassium selective ion channels of axons, so called because they change the potassium conductance with a delay after a voltage step.
The name is used to denote any axon like K channel. Various roles for example regulation of pacemaker potentials, generation of bursts of action potentials or generation of long plateaus on action potentials.
(18 Nov 1997)
delayed reflex A reflex in which a little time elapses between stimulus and response.
See: trace conditioned reflex.
(05 Mar 2000)
delayed sensation A sensation that is not perceived until the lapse of an appreciable interval following the application of the stimulus.
General sensation, a sensation referred to the body as a whole rather than to any particular part.
(05 Mar 2000)
delayed suture A suturing of a wound after an interval of days.
(05 Mar 2000)
delayed type hypersensitivity <immunology> Hypersensitivity (increased reaction by the body to a foreign substance such as an antigen or allergen) that does not appear until 24 to 48 hours after the body is exposed to the foreign substance.
(09 Oct 1997)
ovum implantation, delayed Delay of embryonal development whereby the blastocyst remains in the uterine cavity for a variable period of time before attaching to the endometrium and continuing its development.
(12 Dec 1998)
arterial transfusion Direct transfusion from an artery of the donor into an artery of the receptor.
(05 Mar 2000)
blood component transfusion The transfer of blood components such as erythrocytes, leukocytes, platelets, and plasma from a donor to a recipient or back to the donor. This process differs from the procedures undertaken in plasmapheresis and types of cytapheresis (plateletpheresis and leukapheresis) where, following the removal of plasma or the specific cell components, the remainder is transfused back to the donor.
(12 Dec 1998)
blood transfusion The process of infusing blood products into a patient to raise the individuals concentration of red blood cells. Blood is typed (A, B, O or AB) and crossmatched (mixed together to see if its compatible) prior to transfusion.
(27 Sep 1997)
blood transfusion, autologous Reinfusion of blood or blood products derived from the patient's own circulation.
(12 Dec 1998)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 9 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • fusion reaction
    ÇÙÀ¶ÇÕ ¹ÝÀÀ
  • nuclear reaction
    ÇÙ¹ÝÀÀ
  • protective reaction
    ¹æ¾î ¹ÝÀÀ(ÀÚÀ§,º¸º¹À» ¸ñÀûÀ¸·Î ÇÑ Æø°Ý)
  • reaction
    ¹ÝÀÛ¿ë;¹ÝÇ×;¹Ý¹ß;(Á¤Ä¡»óÀÇ)¹Ýµ¿;¿ªÇà;(ÀÚ±Ø.»ç°Ç.¿µÇ⠵ ´ëÇÑ)¹ÝÀÀ;ŵµ;Àǰß;Àλó;(°ú·Î.±äÀå.ÈïºÐ ÈÄÀÇ)Ȱ·Â°¨Åð;¹«±â·Â;¹ÝÀÀ;¹ÝÀÛ¿ë;¹Ýµ¿·Â;ÇÙ¹ÝÀÀ;¹ÝÃæ ÀÛ¿ë;Àç»ý
  • reaction engine
    (·ÎÄÏÀÇ)¿ªÃßÁø ¿£Áø
  • reaction formation
    ¹Ýµ¿ Çü¼º(»çȸÀû.µµ´öÀûÀ¸·Î ÁÁÁö ¾ÊÀº ¿å±¸³ª ¿ø¸ÁÀ» ¾ïÁ¦Çϱâ À§ÇÏ¿© ÀÌ ¿å±¸¿Í´Â ¹Ý´ë ¹æÇâÀÇ µ¶´ÜÀû ÇൿÀ» ÃëÇÏ´Â ¹«ÀǽÄÀû ÇàÀ§)
  • reaction shot
    ¾ó±¼¿¡ ³ªÅ¸³ª´Â ¹ÝÀÀÀ» Àâ´Â ¼ô;Ç¥Á¤ÀÇ Å¬·ÎÁî¾÷
  • reaction time
    ¹ÝÀÀ ½Ã°£
  • thermonuclear reaction
    ¿­ÇÙ ¹ÝÀÀ
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
ÅëÇÕ°Ë»ö ¿Ï·á